KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Invested Capital (2021 - 2024)

Historic Return on Invested Capital for Bionano Genomics (BNGO) over the last 8 years, with Q3 2025 value amounting to 0.72%.

  • Bionano Genomics' Return on Invested Capital rose 9900.0% to 0.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.72%, marking a year-over-year increase of 9900.0%. This contributed to the annual value of 1.49% for FY2024, which is 2800.0% down from last year.
  • As of Q3 2025, Bionano Genomics' Return on Invested Capital stood at 0.72%, which was up 9900.0% from 1.43% recorded in Q2 2025.
  • Bionano Genomics' Return on Invested Capital's 5-year high stood at 0.14% during Q2 2021, with a 5-year trough of 2.26% in Q4 2024.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.65% (2023), whereas its average is 1.0%.
  • Per our database at Business Quant, Bionano Genomics' Return on Invested Capital skyrocketed by 16200bps in 2021 and then crashed by -16600bps in 2024.
  • Bionano Genomics' Return on Invested Capital (Quarter) stood at 0.21% in 2021, then plummeted by -137bps to 0.5% in 2022, then plummeted by -290bps to 1.93% in 2023, then decreased by -17bps to 2.26% in 2024, then skyrocketed by 68bps to 0.72% in 2025.
  • Its last three reported values are 0.72% in Q3 2025, 1.43% for Q2 2025, and 1.79% during Q1 2025.